Shenwen Ni
Lawyer/Patent Agent
AllBright Law Suzhou Offices
Personal Profile
Ni Shenwen, a lawyer and patent agent at AllBright Law Suzhou Offices, holds a Master's degree in Pharmaceutical Engineering from Sun Yat sen University. Since 2006, he has been engaged in patent legal services. His clients include multinational pharmaceutical companies, NASDAQ listed pharmaceutical companies and local innovative pharmaceutical technology companies. I have rich experience in the global layout and patent family management of pharmaceutical patents. I have represented hundreds of foreign patents in countries and regions such as the United States, Europe, and Japan, and have been responsible for patent validity analysis, due diligence, and FTO analysis for multiple multinational pharmaceutical companies.
As an acting lawyer, he participated in patent invalidation, civil litigation, and administrative litigation, representing clients in court appearances at the Supreme People's Court, Beijing Intellectual Property Court, Shanghai Intellectual Property Court, and Guangzhou Intellectual Property Court. The technical field involves multiple aspects of the biopharmaceutical field, such as antibodies, vaccines, small molecule compounds, microorganisms, oncolytic viruses, heart stents, biomaterials, gene therapy, diagnostic reagents, personalized medicine, CAR-T, exosomes, etc. Maintain regular visits and business exchanges with top law firms in countries and regions such as the United States, Germany, the United Kingdom, and Japan. I studied European patent law in Munich, Germany in 2010 and American patent law in California, USA in 2011. From 2020 to 2023, he was selected as a recommended intellectual property lawyer for China by the international intellectual property magazine IAM PATENT 1000 for four consecutive years, and was invited to publish multiple English legal articles in Lexology.
As an acting lawyer, he participated in patent invalidation, civil litigation, and administrative litigation, representing clients in court appearances at the Supreme People's Court, Beijing Intellectual Property Court, Shanghai Intellectual Property Court, and Guangzhou Intellectual Property Court. The technical field involves multiple aspects of the biopharmaceutical field, such as antibodies, vaccines, small molecule compounds, microorganisms, oncolytic viruses, heart stents, biomaterials, gene therapy, diagnostic reagents, personalized medicine, CAR-T, exosomes, etc. Maintain regular visits and business exchanges with top law firms in countries and regions such as the United States, Germany, the United Kingdom, and Japan. I studied European patent law in Munich, Germany in 2010 and American patent law in California, USA in 2011. From 2020 to 2023, he was selected as a recommended intellectual property lawyer for China by the international intellectual property magazine IAM PATENT 1000 for four consecutive years, and was invited to publish multiple English legal articles in Lexology.
